DENISER ATMORE: Open Payments
NPI 1740595248 · PARRISH, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 13 payments from 9 companies in 2025. Trend: 2023 $58 · 2024 $189 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 3 | $61 |
| ABBVIE INC. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Gilead Sciences, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
Products named: Korlym, REXULTI, VRAYLAR, Wegovy, MAVYRET, VAXELIS, Kerendia, Auvelity.
Industry payments across AL — which companies pay providers there.
